Rosiridin CAS 100462-37-1: Pharmaceutical Intermediate with Neuroprotective Potential from Rhodiola Rosea

Discover the unique properties of Rosiridin, a vital pharmaceutical intermediate derived from Rhodiola Rosea, offering significant neuroprotective benefits and potential therapeutic applications.

Get a Quote & Sample

Advantages Offered by Rosiridin

Neuroprotection

Benefit from the neuroprotective effects of Rosiridin, crucial for developing treatments for neurodegenerative diseases, aligning with interests in neuroprotective effects. This compound's ability to protect neurons from toxicity makes it a valuable asset.

Cognitive Health Support

Explore the potential of Rosiridin as an MAO inhibitor for improving cognitive functions and treating mood disorders, a significant area for those researching MAO inhibitor Rosiridin.

Natural Origin

Leverage a compound derived from Rhodiola rosea, tapping into the growing demand for plant-based ingredients in pharmaceuticals, which is essential for sourcing Rhodiola rosea derived compounds.

Key Applications

Pharmaceutical Research

Utilize Rosiridin as a key pharmaceutical intermediate in drug discovery and development, particularly for neurological and mood disorders, reflecting its role as a Rosiridin pharmaceutical intermediate.

Neuroscience Studies

Investigate the neuroprotective mechanisms of Rosiridin in academic and clinical research settings, contributing to our understanding of brain health and disease, as explored in studies on neuroprotective effects.

Herbal Medicine Enhancement

Incorporate Rosiridin into formulations or research related to Rhodiola rosea, to better understand and harness the plant's therapeutic properties, supporting the field of Rhodiola rosea derived compounds.

Biochemical Assays

Employ Rosiridin in biochemical assays and as a reference standard for MAO enzyme activity studies, crucial for identifying new MAO inhibitors for therapeutic use.